Serum Visfatin in non-obese male normal and coronary artery disease patients
Pakistan Journal of Physiology · 2021
DOI: 10.69656/pjp.v17i1.1185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Physiology, 2021. Verfasst von Shaheena Naz und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Background: Mechanism of direct cardioprotective action of visfatin is still unclear. The aim of this study was to detect the serum visfatin concentration in healthy males and compare it with non-obese male patients of coronary artery disease to access the cardioprotective role of visfatin. Methodology: It was a cross-sectional, comparative study. Data was collected from July to December 2018 after obtaining informed consent of the subjects. The participants included 20 non-obese healthy males, and non-obese males angiographically confirmed having coronary artery disease. All participants were non-smoker, non-diabetic, and age matched from 35–55 years. Serum visfatin was analyzed using ELISA. Anthropometric measurements including waist circumference, hip circumference, and body mass index was evaluated and correlated with serum visfatin. Statistical analysis was done using SPSS-20. The values were considered significant at p
Zitieren
APA
Naz, S., Khalid, A., Zehra, I., Hamayun, Z., Gill, M., & Lodhi, H. N. (2021). Serum Visfatin in non-obese male normal and coronary artery disease patients. Pakistan Journal of Physiology. https://doi.org/10.69656/pjp.v17i1.1185
Vancouver
Naz S, Khalid A, Zehra I, Hamayun Z, Gill M, Lodhi HN. Serum Visfatin in non-obese male normal and coronary artery disease patients. Pakistan Journal of Physiology. 2021. doi:10.69656/pjp.v17i1.1185
BibTeX
@article{Naz2021,
author = {Naz, Shaheena and Khalid, Attiqa and Zehra, Ijlal and Hamayun, Zuniarah and Gill, Maria and Lodhi, Hifza Noor},
title = {Serum Visfatin in non-obese male normal and coronary artery disease patients},
journal = {Pakistan Journal of Physiology},
year = {2021},
doi = {10.69656/pjp.v17i1.1185}
}
EUVIMED